Victor Kairouz Selected Research

Hemorrhage

1/2020	Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study.
11/2019	Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victor Kairouz Research Topics

Disease

2	Hemorrhage 01/2020 - 11/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Diabetes Mellitus 11/2019
1	Thrombosis (Thrombus) 10/2013
1	Heart Diseases (Heart Disease) 04/2012
1	Heart Failure 04/2012

Drug/Important Bio-Agent (IBA)

2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 11/2019
1	APTIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2020
1	edoxabanIBA 01/2020
1	Clopidogrel (Plavix)FDA Link 01/2020
1	AnticoagulantsIBA 01/2020
1	vorapaxarIBA 11/2019
1	MicroRNAs (MicroRNA)IBA 04/2012
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 04/2012
1	CalciumIBA 04/2012

Therapy/Procedure

3	Therapeutics 01/2020 - 10/2013
1	Cutaneous Administration 04/2012